Following the regional HIMSS event, Jefferies & Company is recommending Allscripts Healthcare Solutions MDRX and McKesson Corporation MCK.
“On the physician side Allscripts (Buy) appeared to be the primary vendor used by attendees,” Jefferies & Company writes.
“We consider McKesson (Buy) the winner [on the hospital vender side] because its clients are going to stick with the vendor even though they feel MCK will have to be pushed on upgrades.”
Allscripts currently trades for $18.78; McKesson trades for $62.45.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in